2018 AHA心肺复苏与心血管急救指南:心跳骤停期间和之后应用抗心律失常药物进行高级生命支持(更新)

2018-11-05 美国心脏协会 Circulation. 2018;138:00–00.

11月5日,美国心脏学会(AHA)官网及Circulation杂志刊登了三篇关于心肺复苏(CPR)和心血管急救的指南更新文件,分别为《2018AHA心肺复苏和心血管急救指南更新:心脏骤停期间和之后立即使用抗心律失常药物进行高级心血管生命支持》、《2018AHA心肺复苏和心血管急救指南更新:儿童高级生命支持》和《2018国际复苏联合会(ILCOR)心肺复苏和心血管急救治疗推荐要点》。

中文标题:

2018 AHA心肺复苏与心血管急救指南:心跳骤停期间和之后应用抗心律失常药物进行高级生命支持(更新)

英文标题:

2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest

发布机构:

美国心脏协会

发布日期:

2018-11-05

简要介绍:

11月5日,美国心脏学会(AHA)官网及Circulation杂志刊登了三篇关于心肺复苏(CPR)和心血管急救的指南更新文件,分别为《2018AHA心肺复苏和心血管急救指南更新:心脏骤停期间和之后立即使用抗心律失常药物进行高级心血管生命支持》、《2018AHA心肺复苏和心血管急救指南更新:儿童高级生命支持》和《2018国际复苏联合会(ILCOR)心肺复苏和心血管急救治疗推荐要点》。

拓展指南:心律失常相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 AHA心肺复苏与心血管急救指南:心跳骤停期间和之后应用抗心律失常药物进行高级生命支持(更新))] GetToolGuiderByIdResponse(projectId=1, id=69e961c001661580, title=2018 AHA心肺复苏与心血管急救指南:心跳骤停期间和之后应用抗心律失常药物进行高级生命支持(更新), enTitle=2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest, guiderFrom=Circulation. 2018;138:00–00., authorId=null, author=, summary=11月5日,美国心脏学会(AHA)官网及Circulation杂志刊登了三篇关于心肺复苏(CPR)和心血管急救的指南更新文件,分别为《2018AHA心肺复苏和心血管急救指南更新:心脏骤停期间和之后立即使用抗心律失常药物进行高级心血管生命支持》、《2018AHA心肺复苏和心血管急救指南更新:儿童高级生命支持》和《2018国际复苏联合会(ILCOR)心肺复苏和心血管急救治疗推荐要点》。 , cover=, journalId=null, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Mon Nov 05 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>11月5日,美国心脏学会(AHA)官网及Circulation杂志刊登了三篇关于心肺复苏(CPR)和心血管急救的指南更新文件,分别为《2018AHA心肺复苏和心血管急救指南更新:心脏骤停期间和之后立即使用抗心律失常药物进行高级心血管生命支持》、《2018AHA心肺复苏和心血管急救指南更新:儿童高级生命支持》和《2018国际复苏联合会(ILCOR)心肺复苏和心血管急救治疗推荐要点》。</div> <div><br> </div>拓展指南:<strong>与<font color=red>心律失常</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=eb8ba1c0016a611c" title="2018 SIGN国家临床指南:冠心病心律失常(152)" target=_blank>2018 SIGN国家临床指南:冠心病心律失常(152)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=fd9f41c0016120f1" title="2018 EHRA共识:心律失常的性别差异" target=_blank>2018 EHRA共识:心律失常的性别差异</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=02b421c0015e5827" title="2018 EHRA/AEPC/ESC意见书:先天性心脏病患者心律失常" target=_blank>2018 EHRA/AEPC/ESC意见书:先天性心脏病患者心律失常</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=fc8a31c0015e3191" title="2018 EHRA意见书:内分泌疾病患者的心律失常管理和设备治疗" target=_blank>2018 EHRA意见书:内分泌疾病患者的心律失常管理和设备治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=344f71c0015699ab" title="2018 EHRA/HRS/APHRS/LAHRS专家共识:心律失常和认知功能" target=_blank>2018 EHRA/HRS/APHRS/LAHRS专家共识:心律失常和认知功能</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8" target=_blank>有关心律失常更多指南</a></ul>, tagList=[TagDto(tagId=70, tagName=心肺复苏), TagDto(tagId=48414, tagName=心血管急救), TagDto(tagId=20420, tagName=抗心律失常药物), TagDto(tagId=82772, tagName=高级生命支持)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9525, appHits=1011, showAppHits=0, pcHits=6819, showPcHits=2613, likes=146, shares=24, comments=7, approvalStatus=1, publishedTime=Sun Nov 11 21:39:25 CST 2018, publishedTimeString=2018-11-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Nov 11 21:39:25 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:26:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 AHA心肺复苏与心血管急救指南:心跳骤停期间和之后应用抗心律失常药物进行高级生命支持(更新))])
2018 AHA心肺复苏与心血管急救指南:心跳骤停期间和之后应用抗心律失常药物进行高级生命支持(更新)
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214157, encodeId=b428121415e21, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:14:30 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214154, encodeId=9dcc1214154c8, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:11:53 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012302, encodeId=41791012302c3, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Sat Aug 28 13:49:43 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966399, encodeId=52ae966399be, content=非常好的一个指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb055503335, createdName=ms5000000457682537, createdTime=Mon May 17 21:49:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370585, encodeId=72bc3e0585f2, content=希望这个APP不断完善!让广大医生护士受益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/01/d0ab1a50f97d35c74786456fa4ed2f31.jpg, createdBy=f52b5152614, createdName=Joan.*, createdTime=Thu Aug 01 00:16:25 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
    2022-04-25 ms6000000621069942

    ***

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214157, encodeId=b428121415e21, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:14:30 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214154, encodeId=9dcc1214154c8, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:11:53 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012302, encodeId=41791012302c3, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Sat Aug 28 13:49:43 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966399, encodeId=52ae966399be, content=非常好的一个指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb055503335, createdName=ms5000000457682537, createdTime=Mon May 17 21:49:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370585, encodeId=72bc3e0585f2, content=希望这个APP不断完善!让广大医生护士受益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/01/d0ab1a50f97d35c74786456fa4ed2f31.jpg, createdBy=f52b5152614, createdName=Joan.*, createdTime=Thu Aug 01 00:16:25 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
    2022-04-25 ms6000000621069942

    ***

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214157, encodeId=b428121415e21, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:14:30 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214154, encodeId=9dcc1214154c8, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:11:53 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012302, encodeId=41791012302c3, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Sat Aug 28 13:49:43 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966399, encodeId=52ae966399be, content=非常好的一个指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb055503335, createdName=ms5000000457682537, createdTime=Mon May 17 21:49:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370585, encodeId=72bc3e0585f2, content=希望这个APP不断完善!让广大医生护士受益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/01/d0ab1a50f97d35c74786456fa4ed2f31.jpg, createdBy=f52b5152614, createdName=Joan.*, createdTime=Thu Aug 01 00:16:25 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
    2021-08-28 karlxun

    受益

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214157, encodeId=b428121415e21, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:14:30 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214154, encodeId=9dcc1214154c8, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:11:53 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012302, encodeId=41791012302c3, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Sat Aug 28 13:49:43 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966399, encodeId=52ae966399be, content=非常好的一个指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb055503335, createdName=ms5000000457682537, createdTime=Mon May 17 21:49:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370585, encodeId=72bc3e0585f2, content=希望这个APP不断完善!让广大医生护士受益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/01/d0ab1a50f97d35c74786456fa4ed2f31.jpg, createdBy=f52b5152614, createdName=Joan.*, createdTime=Thu Aug 01 00:16:25 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
    2021-05-17 ms5000000457682537

    非常好的一个指南

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214157, encodeId=b428121415e21, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:14:30 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214154, encodeId=9dcc1214154c8, content=***, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6978134721, createdName=ms6000000621069942, createdTime=Mon Apr 25 16:11:53 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012302, encodeId=41791012302c3, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ea433051518, createdName=karlxun, createdTime=Sat Aug 28 13:49:43 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966399, encodeId=52ae966399be, content=非常好的一个指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb055503335, createdName=ms5000000457682537, createdTime=Mon May 17 21:49:48 CST 2021, time=2021-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=370585, encodeId=72bc3e0585f2, content=希望这个APP不断完善!让广大医生护士受益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/01/d0ab1a50f97d35c74786456fa4ed2f31.jpg, createdBy=f52b5152614, createdName=Joan.*, createdTime=Thu Aug 01 00:16:25 CST 2019, time=2019-08-01, status=1, ipAttribution=)]
    2019-08-01 Joan.*

    希望这个APP不断完善!让广大医生护士受益!

    0